TL;DR: ML314 Analog (CAS 1052519-84-2) is a chemical compound with molecular formula C22H23ClN4O2 and molecular weight 410.15094 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
4-[4-(2-methoxyphenyl)piperazin-1-yl]-2-methyl-[1]benzofuro[3,2-d]pyrimidine;hydrochloride
Also Known As: ML314 Analog, 4-(4-(2-methoxyphenyl)piperazin-1-yl)-2-methylbenzofuro[3,2-d]pyrimidine hydrochloride, 4-[4-(2-methoxyphenyl)piperazin-1-yl]-2-methyl-[1]benzofuro[3,2-d]pyrimidine hydrochloride, REGID_for_CID_6602823
| Molecular Formula | C22H23ClN4O2 |
| Molecular Weight | 410.15094 g/mol |
| XLogP | 4.44142 |
| Topological Polar Surface Area (TPSA) | 54.6 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Exact Mass | 410.15094 Da |
| Heavy Atoms | 29 |
| Complexity | 527.0 |
| SMILES | CC1=NC2=C(C(=N1)N3CCN(CC3)C4=CC=CC=C4OC)OC5=CC=CC=C52.Cl |
| InChIKey | QVSDJHAWEMNNKT-UHFFFAOYSA-N |
The XLogP value of 4.44142 indicates that ML314 Analog is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 54.6 Ų, ML314 Analog exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, ML314 Analog has 1 hydrogen bond donor(s) and 7 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of ML314 Analog is 1052519-84-2.
The molecular formula of ML314 Analog is C22H23ClN4O2.
The molecular weight of ML314 Analog is 410.15094 g/mol.
You can request a quote for ML314 Analog directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for ML314 Analog and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 1052519-84-2. Our professional technical team will respond with pricing and lead time.